Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) patients who experience brain metastases are usually associated with poor prognostic outcomes. This retrospective study proposed to assess whether bevacizumab or gefitinib can be used to improve the effectiveness of whole brain radiotherapy (WBRT) in managing patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, R.F., Yu, B., Zhang, R.Q., Wang, X.H., Li, C., Wang, P., Zhang, Y., Han, B., Gao, X.X., Zhang, L., Jiang, Z.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685055/
https://www.ncbi.nlm.nih.gov/pubmed/29185589
http://dx.doi.org/10.1590/1414-431X20176073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685055/
https://www.ncbi.nlm.nih.gov/pubmed/29185589
http://dx.doi.org/10.1590/1414-431X20176073

Ejemplares similares